Skip to main content
. 2023 May 3;20(1):2206392. doi: 10.1080/15502783.2023.2206392

Table 2.

Baseline characteristics of participants.

    Prior placebo food Prior active food p-value
Age years 53.6 ± 7.3 51.9 ± 5.0 0.562
Height cm 166.1 ± 4.6 169.8 ± 5.2 0.141
Weight kg 65.7 ± 7.8 65.5 ± 3.5 0.963
BMI kg/m2 23.8 ± 2.4 22.8 ± 1.8 0.356
Soft lean mass kg 47.5 ± 4.8 46.6 ± 2.4 0.604
Body fat % 23.2 ± 4.0 24.5 ± 3.5 0.488
BP systolic mmHg 122.5 ± 13.4 124.2 ± 14.1 0.799
BP diastolic mmHg 77.8 ± 7.2 81.9 ± 9.9 0.338
Heart rate bpm 68.1 ± 7.5 71.6 ± 9.3 0.405
Muscle strength 72.3 ± 36.4 68.1 ± 18.0 0.755
Number of squat set sets 5.0 ± 0.0 5.0 ± 0.0 -
Muscle soreness VAS mm 59.9 ± 23.2 58.7 ± 27.6 0.921

The maximum knee extension force during isometric muscle contraction of both legs was measured using a leg muscle strength measuring chair. Participants performed a maximum of five sets of 40 bodyweight squats. Muscle soreness was assessed with VAS on the following day of bodyweight squats.

p-value is for inter-group comparisons by t-test.

Prior placebo food group: n = 8; Prior active food group: n = 10.

Data are presented as mean ± SD. BMI: body mass index, BP: blood pressure.